Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
PharmAbcine to present new interim data from its ongoing mTNBC trial at SABCS 2020 2020-12-07 21:00
INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19 2020-12-07 21:00
Antengene Announces Acceptance of IND Application in China for ATG-010 (selinexor) in Combination with R-GDP (SR-GDP) for the Treatment of rrDLBCL in a Global Phase 2/3 Study 2020-12-07 08:00
CARsgen Therapeutics Presents Updated Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition 2020-12-06 19:00
I-Mab Accelerates Clinical Development of Anti-CD47 Monoclonal Antibody Lemzoparlimab in the US and China 2020-12-04 21:00
Samsung Biologics drives digital transformation with Plant 4 Virtual Showroom launch 2020-12-04 20:00
Polygiene and Eye-care innovator Body Doctor now increase the range of soothing eye compresses and face masks 2020-12-04 16:23
Ascentage Pharma Appoints Mr. Gang Zhu as Chief Commercial Officer to Lead Commercial Initiatives 2020-12-04 08:28
Subcutaneously Administered PD-L1 Antibody ASC22 (Envafolimab) is Safe and Well Tolerated in Phase IIa HBV Study 2020-12-04 08:00
Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for COVID-19 2020-12-03 22:17
INOVIO Expands Global Manufacturing Consortium For Its COVID-19 Vaccine Candidate INO-4800 With Addition of Kaneka Eurogentec S.A. 2020-12-03 21:00
Sihuan Pharmaceutical (0460) Won the Fifth "Listed Enterprises of the Year 2020" Presented by Bloomberg Businessweek/Chinese Edition 2020-12-03 10:36
WuXi AppTec Applauded by Frost & Sullivan for Its Unmatched Breadth of Expertise in Facilitating Early-stage Innovation and Clinical Research 2020-12-02 22:00
Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA to Advance New Generation of Antibody-Drug Conjugates towards Clinical Evaluation 2020-12-02 19:00
Regent Pacific's Strategic Partner Receives Approval from NMPA to Submit IND Application 2020-12-02 18:35
Central IVF Limited's Egg Donation Service Recognized as One of The Most Reputable in Australia 2020-12-02 16:44
Ascentage Pharma Announces Clearances in China and the US for the Phase IIa Study of APG-115 Single Agent or in Combination with APG-2575 for the Treatment of Relapsed or Refractory T-cell Prolymphocytic Leukemia 2020-12-02 08:09
I-Mab Files Shelf Registration Statement for PIPE Investors 2020-12-02 05:23
Bora Pharmaceuticals completes acquisition of former GSK facility 2020-12-01 23:57
I-Mab Appoints Leading Immunology and Hematology Experts to Its Scientific Advisory Board 2020-12-01 21:00
1 268 269 270 271 272 412